Company intelligence / Profile preview

URIS Medical

Gangnam-gu, Seoul, South Korea

Ownership: Private
Development stage: Other

Overview

Uris Medical is a South Korean medical technology company specializing in non-invasive neuromodulation solutions for urological conditions. The company's flagship product, URIS, is a wearable device designed to treat overactive bladder (OAB) by stimulating the posterior tibial nerve. This technology provides a portable and user-friendly alternative to traditional clinical Percutaneous Tibial Nerve Stimulation (PTNS) procedures. Uris Medical aims to improve the quality of life for patients suffering from urinary incontinence through innovative digital healthcare and bioelectronic medicine. The company has received regulatory clearance in South Korea and is actively pursuing international expansion.

Therapeutic areas: UrologyNephrology
Modalities: DeviceNeuromodulation
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on URIS Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on URIS Medical.

Explore the full profile